Aleksei Suslov1, Marie-Anne Meier2, Sylvia Ketterer1, Xueya Wang1, Stefan Wieland3, Markus Hermann Heim4. 1. Department of Biomedicine, University Hospital Basel, University of Basel, Basel, CH-4031, Switzerland. 2. Department of Biomedicine, University Hospital Basel, University of Basel, Basel, CH-4031, Switzerland; Division of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases, Basel, CH-4002, Switzerland. 3. Department of Biomedicine, University Hospital Basel, University of Basel, Basel, CH-4031, Switzerland. Electronic address: stefan.wieland@unibas.ch. 4. Department of Biomedicine, University Hospital Basel, University of Basel, Basel, CH-4031, Switzerland; Division of Gastroenterology and Hepatology, University Center for Gastrointestinal and Liver Diseases, Basel, CH-4002, Switzerland. Electronic address: markus.heim@unibas.ch.
Abstract
BACKGROUND & AIMS: HBeAg seroconversion during the natural history of chronic hepatitis B (CHB) is associated with a strong drop in serum HBV DNA levels and a reduction of intrahepatic covalently closed circular DNA (cccDNA) content. Of particular interest is the transition to HBeAg-negative chronic infection (ENCI). ENCI, previously known as inactive carrier state, is characterized by very low or negative viremia and the absence of liver disease. The molecular mechanisms responsible for the transition to ENCI and for the control of viral replication in ENCI are still poorly understood. METHODS: To identify which step(s) in the viral life cycle are controlled during the transition to ENCI, we quantified cccDNA, pre-genomic RNA (pgRNA), total HBV RNA and DNA replicative intermediates in 68 biopsies from patients in different phases of CHB. RESULTS: HBeAg seroconversion is associated with a reduction of cccDNA amounts as well as transcriptional activity. Silencing of cccDNA is particularly pronounced in ENCI, where there was ~46 times less pgRNA per cccDNA compared to HBeAg-negative CHB. Furthermore, a subgroup of patients with HBeAg-negative CHB can be characterized by reduced replication efficiency downstream of pgRNA. CONCLUSIONS: The reduction in serum viral load during the transition to ENCI seems to primarily result from strong inhibition of the transcriptional activity of cccDNA which can be maintained in the absence of liver disease. LAY SUMMARY: During the natural course of chronic hepatitis B virus infections, the immune response can gain control of viral replication. Quantification of viral DNA and RNA in liver biopsies of patients in different stages of chronic hepatitis B allowed us to identify the steps in the viral life cycle that are affected during the transition from active to inactive disease. Therapeutic targeting of these steps might induce sustained inhibition of viral transcription.
BACKGROUND & AIMS: HBeAg seroconversion during the natural history of chronic hepatitis B (CHB) is associated with a strong drop in serum HBV DNA levels and a reduction of intrahepatic covalently closed circular DNA (cccDNA) content. Of particular interest is the transition to HBeAg-negative chronic infection (ENCI). ENCI, previously known as inactive carrier state, is characterized by very low or negative viremia and the absence of liver disease. The molecular mechanisms responsible for the transition to ENCI and for the control of viral replication in ENCI are still poorly understood. METHODS: To identify which step(s) in the viral life cycle are controlled during the transition to ENCI, we quantified cccDNA, pre-genomic RNA (pgRNA), total HBV RNA and DNA replicative intermediates in 68 biopsies from patients in different phases of CHB. RESULTS: HBeAg seroconversion is associated with a reduction of cccDNA amounts as well as transcriptional activity. Silencing of cccDNA is particularly pronounced in ENCI, where there was ~46 times less pgRNA per cccDNA compared to HBeAg-negative CHB. Furthermore, a subgroup of patients with HBeAg-negative CHB can be characterized by reduced replication efficiency downstream of pgRNA. CONCLUSIONS: The reduction in serum viral load during the transition to ENCI seems to primarily result from strong inhibition of the transcriptional activity of cccDNA which can be maintained in the absence of liver disease. LAY SUMMARY: During the natural course of chronic hepatitis B virus infections, the immune response can gain control of viral replication. Quantification of viral DNA and RNA in liver biopsies of patients in different stages of chronic hepatitis B allowed us to identify the steps in the viral life cycle that are affected during the transition from active to inactive disease. Therapeutic targeting of these steps might induce sustained inhibition of viral transcription.
Authors: Andrea Magri; James M Harris; Valentina D'Arienzo; Rosalba Minisini; Frank Jühling; Peter A C Wing; Rachele Rapetti; Monica Leutner; Barbara Testoni; Thomas F Baumert; Fabien Zoulim; Peter Balfe; Mario Pirisi; Jane A McKeating Journal: Viruses Date: 2022-05-17 Impact factor: 5.818
Authors: Raymond T Chung; Wendy C King; Marc G Ghany; Mauricio Lisker-Melman; Amanda S Hinerman; Mandana Khalili; Mark Sulkowski; Mamta K Jain; Eun-Young K Choi; Michael A Nalesnik; Atul K Bhan; Gavin Cloherty; David K Wong; Richard K Sterling Journal: Clin Gastroenterol Hepatol Date: 2021-12-29 Impact factor: 13.576
Authors: Dara L Burdette; Scott Lazerwith; Jenny Yang; Henry L Y Chan; William E Delaney Iv; Simon P Fletcher; Tomas Cihlar; Becket Feierbach Journal: PLoS One Date: 2022-04-01 Impact factor: 3.240
Authors: Marc G Ghany; Wendy C King; Mauricio Lisker-Melman; Anna S F Lok; Norah Terrault; Harry L A Janssen; Mandana Khalili; Raymond T Chung; William M Lee; Daryl T Y Lau; Gavin A Cloherty; Richard K Sterling Journal: Hepatology Date: 2021-09-09 Impact factor: 17.298